FAMDF (Futura Medical) 1-Year Share Buyback Ratio : -0.80% (As of Dec. 2024 )

View and export this data going back to 2007. Start your Free Trial

What is Futura Medical 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Futura Medical's current 1-Year Share Buyback Ratio was -0.80%.

FAMDF's 1-Year Share Buyback Ratio is ranked better than
81.23% of 1204 companies
in the Biotechnology industry
Industry Median: -13.8 vs FAMDF: -0.80

Competitive Comparison of Futura Medical's 1-Year Share Buyback Ratio

For the Biotechnology subindustry, Futura Medical's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Futura Medical's 1-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Futura Medical's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Futura Medical 1-Year Share Buyback Ratio Calculation

Futura Medical's 1-Year Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2023 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Dec. 2023 )
	=	(301.406	-	303.704)	/	301.406
	=	-0.8%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Futura Medical (OTCPK:FAMDF) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Futura Medical 1-Year Share Buyback Ratio Related Terms

Futura Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (OTCPK:FAMDF) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

FUM:UK GYX:Germany

Address

40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG

Website

https://www.futuramedical.com

Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.